Archives: 9/2007

3254face 3D Face Scan for Diagnosis of Genetic SyndromesProfessor Peter Hammond from the Institute of Child Health at the University College London has developed software that can scan facial features of children, and offer a likely diagnosis from over 700 genetic conditions. According to Dr. Hammond’s report, presented at the ongoing BA Festival of Science by the British Association for the Advancement of Science, his software is pretty accurate in making the diagnosis:

There are over 700 genetic conditions associated with characteristic facial features. Fragile X, the most common form of inherited mental impairment, affects one birth in 4,000. Children with the condition have longer, narrower faces, with bigger jaws and ears that stick out very slightly.
Smith-Magenis syndrome affects one birth in 25,000. It produces a nose with a flat bridge and an upper lip that looks as though it’s been lifted up from the inside. Children with this condition can be aggressive and self-harming. They sleep in the daytime and are awake at night.
The new software has identified Fragile X faces with an accuracy of 92%; Smith-Magenis syndrome at 91% and Williams syndrome at 98%.

A snippet on how the software works:

The specially written software is based on dense surface modelling techniques developed at UCL and compares the child’s face to groups of individuals with known conditions and selects which syndromes look most similar. In order to do this, extensive collections of 3D face images of children and adults with the same genetic condition had to be gathered, as well as controls or individuals with no known genetic condition. Each image contains 25,000 or so points on a face surface capturing even the most subtle contours in 3D. The images are then converted to a compact form that requires only a 100 or so numeric values to represent each face in the subsequent analysis.
Once the software has narrowed down conditions with similar facial features, molecular testing can then be used to confirm the diagnosis. Testing for fewer conditions will save money, time and reduce the amount of stress the child and the parents are put under.
So far the technique has proved fruitful, Professor Hammond says: ‘The technique is currently being applied to over 30 conditions with an underlying genetic abnormality. The discriminatory capability of the approach has proven highly accurate in identifying the characteristic facial features of a variety of genetic conditions, including Cornelia de Lange, Fragile X, Noonan, Smith-Magenis and Velocardiofacial syndromes. It has identified unusual facial asymmetry in children with autism spectrum disorder reflecting known brain asymmetry and has helped to identify genes affecting facial development in Williams syndrome.’

Press release @ the-BA: Faces reveal genetic conditions …
Press release @ UCL: Facial characteristics offer insights into genetic conditions …

436534torn Warrior Wear®, an Integrated Tourniquet Clothing System that Promises to Save LivesHere’s an interesting new product idea for the military personnel in the field: an apparel line with integrated tourniquets for the extremities. Mike Noell, President and CEO of Blackhawk!! Products Group™, a military and law enforcement equipment maker, just revealed the company’s work on Warrior Wear®:

“At Blackhawk we get up every morning dedicated to using our resources to help save lives,” explained Noell. “When medics and doctors that deal with combat and tactical medical needs see the system, they at once understand the immediate life saving potential. Four tourniquets in the pants and four tourniquets in the shirt (two in the short sleeve version), correctly positioned and oriented to the upper and lower extremities, are immediately accessible under existing gear and can be operated by the wearer, their buddy, or a medic.
Immediate application minimizes loss of blood, the single greatest medical problem resulting in death from injuries sustained to the extremities among our troops today. An additional feature is that our design allows users to train with the system over and over rather than having to replace each tourniquet after a single use, whether during training or in the field using the same system they will wear in tactical operation,” further explained Noell.
“The Integrated Tourniquet System (I.T.S.™) was the brainchild of Dr. Keith Rose. Dr. Rose, a tactical medicine consultant for Blackhawk’s Special Operations Division, was in the military for several years on a forward surgical team and has extensive field experience in trauma and burns. He is currently working with humanitarian groups worldwide and worked directly with Blackhawk!’s R&D team to make sure that the system met real world requirements, and was also consistent with the medical training doctrine typically used by Military, Law Enforcement and the Civilian communities,” elaborated Eric Yeates, Director of Blackhawk’s R&D. “Blackhawk’s Injection Molding Team collaborated on the patent pending design of the Tourniquet System; our Apparel design teams designed the pants and shirts to carry the system, and our Factory’s rapid prototyping capability allowed us to get sample systems into the hands of users very early in the design process so we could incorporate their input from the beginning of the project,” concluded Yeates.

Press release: BlackHawk® Focuses on the Most Common Cause of Preventable Deaths in Tactical Environment with Launch of its Integrated Tourniquet System™ …
(hat tip: gizmag)

453434eed New Nanostructs Show Enhanced Absorption of Light
Improving light absorbing properties of titanium oxide and iron has led researchers from Brookhaven National Laboratory to develop hitherto unknown nano-formulations, that might have applications for clinical medicine:

The research is published in two papers now available online, one in Advanced Materials (August 22, 2007), and the other in the Journal of Physical Chemistry (September 8, 2007).
In the first study, the scientists enhanced the ability of titanium oxide to absorb light.
“Titanium dioxide’s ability to absorb light is one the main reasons it is so useful in industrial and medical applications,” said Wei-Qiang Han, a scientist at Brookhaven’s Center for Functional Nanomaterials…
Many scientists have explored ways to improve the light-absorbing capability of titanium oxide, for example, by “doping” the material with added metals. Han and his coworkers took a new approach. They enhanced the material’s light-absorption capability by simply introducing nanocavities, completely enclosed pockets measuring billionths of a meter within the 100-nanometer-diameter solid titanium oxide rods.
The resulting nanocavity-filled titanium oxide nanorods were 25 percent more efficient at absorbing certain wavelengths of ultraviolet A (UVA) and ultraviolet B (UVB) solar radiation than titanium oxide without nanocavities.
“Our research demonstrates that titanium oxide nanorods with nanocavities can dramatically improve the absorption of UVA and UVB solar radiation, and thus are ideal new materials for sunscreen,” Han said.
The cavity-filled nanorods could also improve the efficiency of photovoltaic solar cells and be used as catalysts for splitting water and also in the water-gas-shift reaction to produce pure hydrogen gas from carbon monoxide and water.
The method for making the cavity-filled rods is simple, says Han. “We simply heat titanate nanorods in air. This process evaporates water, transforming titanate to titanium oxide, leaving very densely spaced, regular, polyhedral nanoholes inside the titanium oxide.”
In the second paper, Han and his collaborators describe a new synthesis method to make iron-doped titanate nanotubes, hollow tubes measuring approximately 10 nanometers in diameter and up to one micrometer (one millionth of a meter) long. These experiments were also aimed at improving the material’s photoreactivity. The scientists demonstrated that the resulting nanotubes exhibited noticeable reactivity in the water-gas-shift reaction.

Tiny Tubes and Rods Show Promise as Catalysts, Sunscreen …

854289hear Tissue Engineered Heart Valves That Grow with PatientVirna Sales, MD and colleagues at the Department of Cardiac Surgery at Children’s Hospital Boston developed tissue-engineered cardiac valves that once transplanted will grow together with the patient. Their work is being reported in today’s Circulation. Medgadget had a news flash about this story back on August 22.
From the statement by Children’s Hospital Boston:

The researchers, led by Sales and senior investigator John Mayer, MD, in Children’s Department of Cardiac Surgery, first isolated endothelial progenitor cells (precursors of the cells that line blood vessel walls) from the blood of laboratory animals. They then “seeded” the cells onto tiny, valve-shaped biodegradable molds and pre-coated with proteins found in the natural “matrix” that surrounds and supports cells.
Experimenting with different matrix proteins and growth factors, they were able to make pulmonary valve leaflets that had the right mechanical properties — sturdy yet pliable. Tests showed the original cells had differentiated to form both endothelial cells and smooth-muscle-like cells and added to the surrounding matrix to hold them together.
With grants from the American Heart Association and the Cambridge, Mass.-based Center for Integration of Medicine and Innovative Technology (CIMIT), Sales is now refining the lab-grown valves by exposing them to mechanical stress in a bioreactor. She is also using a “cardiac jelly” — a cushiony material rich in matrix components and growth factors — to encourage cells to differentiate and form a heart valve on their own, with only minimal reliance on an artificial scaffold. “I would like to mimic what really happens in the embryo — what Mother Nature does,” she says. The next step would be to implant the living valves into animals.
Sales and surgical research fellow Bret Mettler, MD, have already used tiny tissue-engineered patches in sheep to rebuild a portion of the pulmonary artery — an area that often needs augmentation in patients with congenital heart disease. Eventually, Sales hopes to use tissue-engineering techniques to create “living stents” for adults with atherosclerosis.

Press release: A step toward tissue-engineered heart structures for children …

46234onco OncologySTAT Breaks Some Ground; We Want More
OncologySTAT is a new website aimed at oncologists, internal medicine docs and others, that has just been launched by Reed Elsevier. For signing up, and revealing some of your professional info, Reed Elsevier will allow you to browse through scientific articles from more than 100 of the company’s scientific journals. The OncologySTAT site will feature ads to a targeted audience of medical professionals, and that will be the main source of revenue. According to the New York Times, the company also plans to capitalize “the site’s list of registered professionals, which it can sell to advertisers.” In other words, you might as well get ready for a flood of unsolicited emails.
We checked out the site, and found it to be well structured, and full of the latest scientific content. The ‘blogs and forums” section is still almost empty.
From the announcement:

“OncologySTAT is a first for getting a broad range of the latest evidence-based oncology information and news into the hands of health professionals in a manner that fits the practitioner’s workflow and time-constraints, so they can spend more time treating patients,” said Brian Nairn, CEO, Elsevier Health Sciences. “OncologySTAT matches the user’s need for rapid integrated access to the latest trusted oncology information with the pharmaceutical industry’s growing need and desire to communicate directly with oncology practitioners via credible online channels.”

The New York Times believes that a subscription-free site is a new business model for large scientific publishers such as Elsevier. While we agree that this is a step in the right direction, we still believe that the science–especially the tax-payer supported science, like most of it is–has to be open to all to be learned, taught, and reviewed, and it has to be free from registrations and constraints. One can only wonder when AMA’s (American Medical Association) journals will become free and open.
The New York Times: A Medical Publisher’s Unusual Prescription: Online Ads …
Press release: Elsevier’s OncologySTAT Delivers Unprecedented Free Portal for Integrated Professional Cancer Information and Clinical Resources …
OncologySTAT

4334salk Ins and Outs

  • Normal Role for Schizophrenia Risk Gene Identified…
    [Johns Hopkins]
  • Researchers Develop Mouse Model of Autism Spectrum Disorders …
    [Howard Hughes Medical Institute]
  • Researcher developing new method for hearing loss assessment …
    [Purdue University]
  • How Insulin TORCs Blood Sugar Levels: Glowing Mice Light the Way …
    [Salk Institute]
  • New lung cancer guidelines oppose general CT screening …
    [American College of Chest Physicians]
  • Study Finds Evidence of Genetic Response to Diet …
    [NY Times]
  • Treat the Patient–Not the Computer …
    [WSJ Health Blog]
  • Why did the monkey pee on his feet? …
    [Nature]
  • Nice but naughty — our addiction to chocolate …
    [University of Bristol]
  • verichipskin Old News New AgainAn enterprising reporter at the Associated Press managed to make news out of three aging and obscure studies, involving RFID chips implanted in animals, that mentioned increased occurrence of tumors. Two were written a decade ago, and one just last year. The AP is wondering whether these studies should have prevented FDA approval of RFID implants in humans, and if so, how could the findings have been ignored.

    “Published in veterinary and toxicology journals between 1996 and 2006, the studies found that lab mice and rats injected with microchips sometimes developed subcutaneous “sarcomas” – malignant tumors, most of them encasing the implants.
    * A 1998 study in Ridgefield, Conn., of 177 mice reported cancer incidence to be slightly higher than 10 percent – a result the researchers described as “surprising.”
    * A 2006 study in France detected tumors in 4.1 percent of 1,260 microchipped mice. This was one of six studies in which the scientists did not set out to find microchip-induced cancer but noticed the growths incidentally. They were testing compounds on behalf of chemical and pharmaceutical companies; but they ruled out the compounds as the tumors’ cause. Because researchers only noted the most obvious tumors, the French study said, “These incidences may therefore slightly underestimate the true occurrence” of cancer.
    * In 1997, a study in Germany found cancers in 1 percent of 4,279 chipped mice. The tumors “are clearly due to the implanted microchips,” the authors wrote.
    Caveats accompanied the findings. “Blind leaps from the detection of tumors to the prediction of human health risk should be avoided,” one study cautioned. Also, because none of the studies had a control group of animals that did not get chips, the normal rate of tumors cannot be determined and compared to the rate with chips implanted. “

    Read for all the details from the Associated Press
    VeriChip Corp responds
    Flashback: VeriChip

    43534swe1 In the Works: Ultra Miniature Surgical Instruments
    How about 1 mm wide MEMS forceps, at the end of an intravascular catheter, for intracardiac minimally invasive procedures? The research to develop such miniaturized instruments is being conducted by Boston University’s College of Engineering, working together with Children’s Hospital Boston, and Microfabrica, Inc., a California-based microdevice manufacturer.
    43534swe2 In the Works: Ultra Miniature Surgical Instruments
    EFAB™ micro-fabrication technology from Microfabrica is touted to allow the development and commercialization of super-miniature mechanical devices. Here’s a look at the technology:
    43534swe3 In the Works: Ultra Miniature Surgical Instruments

    EFAB technology is an additive microfabrication process based on multi-layer selective electrodeposition of metals. The process is designed to rapidly stack large numbers of independently patterned metal layers on top of each other, allowing designers to create intricate 3-D complex geometries with micron-level precision. EFAB is a batch process like semiconductor manufacturing in which many devices are built simultaneously on wafers, allowing volume production at low cost.
    The essence of the approach is a basic three-step process that is used to generate each layer. This is repeated as many times as there are layers to build the desired complex devices. These steps are:

  • Patterned layer deposition
  • Blanket layer deposition
  • Planarization
  • In the first step, a layer of metal (the sacrificial metal in this case) is deposited in a pattern corresponding to a cross section of the device to be fabricated.
    In the second step, a second material is electroplated onto the substrate, covering the previous layer completely.
    Finally, in the third step, the two materials are planarized to yield a single two-material layer.
    To continue building the device, the same process is repeated over and over, adding layer after layer until all cross sections of the original 3-D CAD design have been constructed in the desired structural material.
    This basic EFAB process used two materials, one structural, and one sacrificial.

    Press release: ‘Heart’ Work Earns Professor Pierre Dupont NIH Grant …
    EFAB Technology page…

    crocs float Croc Filled Controversy
    Crocs just keep on coming up with exciting new ways to make “comfy” shoes dangerous, whether it’s static electricity build-up, needlesticks, and now the somewhat dramatic getting your foot sucked into an escalator.
    In Japan, 40 reports of feet getting caught in escalators have been linked to Croc-brand or imitation Croc shoes. In one case, a 5-year-old girl broke her middle toe.
    Bottom line: If you work in a hospital with sensitive electronics, frequently flying needles and hungry escalators, for the love of your feet, don’t wear Crocs.
    (Hat Tip: Engadget)
    Read the article here